How to Buy Aligos Therapeutics Stock
Aligos Therapeutics Inc
Aligos Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases.
Aligos Therapeutics stock last closed at $9.22, up 3.02% from the previous day, and has decreased 35.93% in one year. It has overperformed other stocks in the Biotechnology industry by 0.12 percentage points. Aligos Therapeutics stock is currently +145.21% from its 52-week low of $3.76, and -80.3% from its 52-week high of $46.80.
At the moment, there are 6.15M ALGS shares outstanding. The market cap of ALGS is $56.72M. In the past 24 hours, 39,300 ALGS shares were traded.
How to Buy Aligos Therapeutics Stock
Not sure how to invest in Aligos Therapeutics stock? Here's how.
- Figure out where to buy Aligos Therapeutics stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you determine where to buy Aligos Therapeutics stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your investment account: Select your payment method and add your information.
- Evaluate Aligos Therapeutics stock: The Aligos Therapeutics ticker symbol is ALGS. Is Aligos Therapeutics stock a good investment? Should you buy shares of ALGS? How do ALGS's underlying business fundamentals look? Do top analysts think Aligos Therapeutics is a good buy? Why has ALGS's stock price moved recently? (Hint: Our stock research tools can help you figure out if ALGS is a good stock to buy).
- Make your ALGS purchase: Decide if you will purchase ALGS shares at the current market price or use a limit order to buy ALGS shares at a given price.
- Get the latest scoop on your ALGS investment: Create a watchlist to get live updates on your new investment in Aligos Therapeutics shares.
Step 1: Figure out where to buy Aligos Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy ALGS stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Technology to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal information so you can invest in ALGS today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new brokerage account.
- Submit your info by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have created your account on a mobile trading app, you need to deposit funds:
Check out the walkthrough below to see the process of depositing funds into your brokerage account.
Step 4: Evaluate Aligos Therapeutics stock
After you have identified the best place to buy Aligos Therapeutics stock, it's critical to research their stock before you buy, so you truly wrap your head around the risk and upside.
Aligos Therapeutics Metrics
ALGS Due Diligence Score
WallStreetZen was created to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ALGS's stock page.
Is ALGS stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge ALGS's intrinsic value.
Using relative valuations measures:
- ALGS could be undervalued based on its P/B ratio of 0.56x, relative to Biotechnology industry P/B ratio of 4.69x
You can do additional valuation analysis on ALGS's stock here.
ALGS Financial Health Summary
Signs that ALGS is financially healthy:
- There are more short-term assets than short-term liabilities on the ALGS balance sheet.
- ALGS has a low debt to equity ratio of 0.32.
- ALGS has cash burn of 75123000. It has sufficient cash and short-term investments to cover this for at least one year.
- Total ALGS debt is lower than 5 years ago, relative to shareholder equity.
- ALGS has $123.06M in cash and short term investments. This is sufficient to cover its annual cash burn of $75.12M.
- There are more short-term assets than long-term liabilities on the ALGS balance sheet.
Signs that ALGS is not financially healthy:
- ALGS profit margin has gone down from -950.6% to -2,337.2% in the past year.
Do Wall Street analysts think it's a good time to buy Aligos Therapeutics stock
Out of 2 Wall Street analysts who give forecasts on ALGS, the consensus analyst rating on Aligos Therapeutics is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Aligos Therapeutics stock forecast page.
Metrics for Advanced ALGS Traders
How are ALGS Revenues/Earnings doing?
Last year, ALGS revenue was $3.17M. Over the past 4 year, ALGS's revenue has grown by 6.63% per year. This was slower than the Biotechnology industry average of 66.41%.
Find out more about ALGS's earnings and revenue performance here.
Are ALGS insiders buying or selling the stock?
Over the past year, insiders at ALGS have not bought or sold any shares.
Research more about who owns ALGS stock here.
Does ALGS provide a stable income stream?
No, Aligos Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about ALGS
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your ALGS purchase
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually the easiest way to buy. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at an exact price, use a limit order.
Click the Open button and eToro will execute the order.
If you require more help buying stocks on eToro, click the helpful video below:
Step 6: Get the latest scoop on your ALGS investment
Now that you own some shares in ALGS, you'll want to keep up with your company.
Put ALGS on a watchlist to track the most important metrics related to your ALGS stock.
ALGS Feed
How to Buy Stock in Aligos Therapeutics
To reiterate, here are the 6 steps you need to take to buy Aligos Therapeutics stock right now:
- Figure out where to buy Aligos Therapeutics stock
- Open a brokerage account
- Fund your investment account
- Evaluate Aligos Therapeutics stock
- Make your ALGS purchase
- Get the latest scoop on your ALGS investment
If you are looking for a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Aligos Therapeutics, hit the button below to create your watchlist.
More "How To" Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.